Organization Overview
Alternative names
atezolizumab (Tecentriq) (1 trial)
bevacizumab (avastin) (1 trial)
cisplatin (platinol) (5 trials)
doxorubicin (Doxil) (3 trials)
erlotinib (tarceva) (2 trials)
indocyanine green (ic-green) (1 trial)
Adenocarcinoma (Phase 2)
Adenocarcinoma of Lung (Phase 2)
Breast Neoplasms (Phase 2)
Cancer Pain (Phase 3)
Carcinoma (Phase 2)
Carcinoma, Hepatocellular (Phase 2)
Carcinoma, Non-Small-Cell Lung (Phase 2)
Carcinoma, Squamous Cell (Phase 3)
Lung Neoplasms (Phase 2)
Lymphoma (Phase 2)
Lymphoma, Extranodal NK-T-Cell (Phase 2)
Lymphoma, T-Cell (Phase 2)
Musculoskeletal Pain (Phase 3)
Myelodysplastic Syndromes (Phase 1)
Nasopharyngeal Carcinoma (Phase 2)
Nausea (Phase 3)
Neoplasm Metastasis (Phase 3)
Neoplasms (Phase 1)
Osteosarcoma (Phase 2)
Pancreatic Neoplasms (Phase 3)
Preleukemia (Phase 1)
Small Cell Lung Carcinoma (Phase 2)
Squamous Cell Carcinoma of Head and Neck (Phase 3)
Urinary Bladder Neoplasms (Phase 2)
Uterine Cervical Neoplasms (Phase 2)
Vomiting (Phase 3)